HKSE - Delayed Quote HKD

CLSA Premium Limited (6877.HK)

0.420
+0.035
+(9.09%)
At close: 4:08:05 PM GMT+8
Loading Chart for 6877.HK
  • Previous Close 0.385
  • Open 0.385
  • Bid 0.405 x --
  • Ask 0.410 x --
  • Day's Range 0.380 - 0.425
  • 52 Week Range 0.070 - 0.445
  • Volume 4,115,000
  • Avg. Volume 5,213,745
  • Market Cap (intraday) 853.982M
  • Beta (5Y Monthly) 1.71
  • PE Ratio (TTM) 42.00
  • EPS (TTM) 0.010
  • Earnings Date Mar 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 19, 2015
  • 1y Target Est --

CLSA Premium Limited, an investment holding company, sells healthcare products and other services in Australia, Hong Kong, and New Zealand. It operates through Healthcare Products and Margin Dealing segments. The company also offers leveraged foreign exchange trading, commodity and index trading, and other trading services. The company was formerly known as KVB Kunlun Financial Group Limited and changed its name to CLSA Premium Limited in November 2019. CLSA Premium Limited was incorporated in 2010 and is headquartered in Wan Chai, Hong Kong. CLSA Premium Limited is a subsidiary of CITIC Securities International Company Limited. As of April 1, 2025, CLSA Premium Limited operates as a subsidiary of Beijing Tong Ren Tang (Cayman) Limited.

www.clsapremium.com

13

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6877.HK

View More

Performance Overview: 6877.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

6877.HK
328.57%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

6877.HK
500.00%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

6877.HK
388.37%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

6877.HK
75.00%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 6877.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6877.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    782.82M

  • Enterprise Value

    569.49M

  • Trailing P/E

    68.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.05

  • Price/Book (mrq)

    3.20

  • Enterprise Value/Revenue

    6.58

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.84%

  • Return on Assets (ttm)

    4.27%

  • Return on Equity (ttm)

    4.68%

  • Revenue (ttm)

    95.77M

  • Net Income Avi to Common (ttm)

    11.34M

  • Diluted EPS (ttm)

    0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.52M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6877.HK

View More

Company Insights: 6877.HK

Research Reports: 6877.HK

View More

People Also Watch